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Two Human T Cell Receptors Bind in a Similar
Diagonal Mode to the HLA-A2/Tax Peptide Complex
Using Different TCR Amino Acids
HLA-A2/Tax peptide complex and of the murine TCR
2C bound to an H-2Kb/peptide complex (Garboczi et al.,
1996a; Garcia et al., 1996) revealed a diagonal binding
mode of the TCR. The TCR fit into a surface feature
common toall MHC molecules, suggesting that the diag-
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tent with subsequent mutagenesis data (Sant'Angelo etDepartment of Medicine
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110, Avenue des Pins Ouest virus HTLV-1 bound the human class I MHC molecule
HLA-A2 (Garboczi et al., 1996a, 1996b). The TCR genesLaboratoire d'Immunologie
MontreÂ al, QueÂ bec H2W 1R7 used to generate the soluble TCR were from a T cell
clone isolated from a patient with HTLV-1±associatedCanada
4Molecular Immunology Section myelopathy/tropical spastic paraparesis (HAM/TSP) (Ro-
man and Osame, 1988; Utz et al., 1996). Patients withNeuroimmunology Branch
National Institute of Neurological Disorders HAM/TSP have a 40-fold higher frequency of HTLV-1±
specific cytotoxic T lymphocytes (CTLs), most of whichand Stroke
National Institutes of Health are specific for the Tax peptide, relative to asymptom-
atic HTLV-1±infected individuals (Elovaara et al., 1993).Bethesda, Maryland 20892
Here we report the three-dimensional structure of the
human ab B7 TCR bound to the same HLA-A2/Tax pep-
tide complex. B7 is the TCR of a T cell clone isolatedSummary
from a second patient with HAM/TSP (Utz et al., 1996).
T cell clones bearing B7 are activated by the same HLA-The three-dimensional structure of a human ab T cell
A2/Tax complex as the A6 TCR, but differ from A6 Treceptor (TCR), B7, bound to the HLA-A2 molecule/
cells in the fine specificity of their reactivity for singlyHTLV-1 Tax peptide complex was determined by x-ray
substituted analogues of the Tax peptide. Different Vacrystallography. Although different from the A6 TCR,
germline genes are used to form B7 and A6, encodingpreviously studied, in 16 of the 17 residues thatcontact
domains with 45% sequence identity; the same Vb germ-HLA-A2/Tax, the B7 TCR binds in a similar diagonal
line gene is used to make B7 and A6, encoding domainsmanner, only slightly tipped and rotated, relative to the
with 96% sequence identity. Our results show that bothA6 TCR. The structure explains data from functional
the B7 and A6 TCRs bind diagonally across the MHC/assays on the specificity differences between the B7
peptide complex, yet only one of the 17 B7 TCR residuesand A6 TCRs for agonist, partial agonist, and null pep-
that contact HLA-A2/Tax is also found in the A6 TCR/tides. The existence of a structurally similar diagonal
MHC/peptide interface. This illustrates how the samebinding mode for TCRs favors mechanisms based on
MHC-bound antigen can be recognized by differentthe formation of geometrically defined supramolecular
TCRs. The structures also explain specificity differencesassemblies for initiating signaling.
between the B7 and A6 TCRs for agonist, partial agonist,
and null peptides. Unlike antibody molecules, which
Introduction bind with many different binding geometries even to the
same antigen, ab TCRs appear to have evolved or to
The recognition of an antigenic peptide bound to a class be selected tobind similarly, in a diagonal binding mode,
I or class II major histocompatibility (MHC) glycoprotein to MHC/peptide complexes. This approximate conser-
by the antigen-specific ab T cell receptor (TCR) deter- vation of binding geometry has implications for the
mines the specificity of a T cell response. Three-dimen- mechanism of initiation of T cell signaling.
sional structures of ab TCR bound to class I MHC/pep-
tide complexes were only recently determined(Garboczi
Resultset al., 1996a; Garcia et al., 1996). The three-dimensional
structures both of the human A6 TCR bound to the
Three-Dimensional Structure Determination
The structure of the B7 TCR bound to the HLA-A2/Tax
5 These two authors contributed equally to this work. peptide (LLFGYPVYV) complex was determined to 2.5
6 Present address: Structural Biology Section, National Institute of AÊ resolution by x-ray crystallography (see Experimental
Allergy and Infectious Diseases, National Institutes of Health, Rock-
Procedures). The soluble ab TCR was expressed asville, Maryland 20852.
separate chains in bacteria and refolded in vitro, in the7 To whom correspondence should be addressed (e-mail: wiley@
xtal0.harvard.edu). presence of an excess of the HLA-A2/Tax complex. The
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Table 1. Data Collection and Refinement Statistics
Low Resolution High Resolution Merged
Resolution limit (AÊ ) 3.6 2.5 2.5
Mosaicity (8) 0.67 1.0
Rmerge (%) 6.8 (13.4) 11.8 (21.3) 11.9 (22.1)
Unique reflections 11874 32111 33899
Total reflections 42955 107903 145021
Completeness (%) 95.7 (89.1) 86.8 (86.0) 91.2 (85.1)
Refinement
Rfree (%) 31.2
Rcryst (%) 23.8
Residues Average B
Protein 815 40.9
Water 39 52.2
rms Deviations
Bonds (AÊ ) Angles (8) B factors (AÊ 2 )
0.010 1.63 4.36
Average B factor by domain
a1a2 a3 b2m Peptide Va Vb Ca Cb
36.4 43.5 45.0 27.1 43.1 31.1 60.6 38.5
Numbers in parentheses indicate the specific value in the resolution shell from 3.73 to 3.6 AÊ for the low-resolution data set and from 2.59 to
2.5 AÊ for the high-resolution and merged data sets.
atomic model includes the TCR Ca domain, which is al., 1998). But when the Cb and Vb domains of the B7
TCR and the A6 TCR are superimposed, the Va domainsdisordered in the A6 TCR complex (Garboczi et al.,
1996a) but is stabilized by lattice contacts in the B7 are displaced by about one half of the distance between
their b strands (Figure 1D). Most of the hydrophobic coreTCR complex crystals. Crystallographic statistics are
presented in Table 1. (a 43, 45, 89, 91; b 43, 45, 1, 93) and polar interactions (a
35, 37; b 35, 37) in this Va±Vb interface are conserved
both in the ternary complexes of the A6 and B7 TCRComparison of the B7 and A6 TCR Binding Modes
When the HLA-A2 a1a2 domains are superimposed (root- and the other known TCR structures (Garboczi et al.,
1996a; Garcia et al., 1996; Wang et al., 1998). The differ-mean square [rms] deviation 5 0.46 AÊ ), the TCR mole-
cules B7 and A6 are both positioned diagonally binding ences between B7 and A6 TCR in the Va±Vb interface
are mostly near the CDR loops, where both of the CDR3across the peptide-binding site of HLA-A2 (Figures 1A
and 1B). The three variable loops of the Va domain of loops of B7 are one residue shorter than A6 (Figures
1D and 2A). The differences decrease the number ofthe B7 TCR superimpose on those of the A6 TCR closely,
with a minor difference at CDR2 (1 AÊ ; Figure 1A). The contacts at one side of the interface, such that the Va±Vb
interface of B7 is more like that of uncomplexed 2C TCRVb CDR loops of the B7 TCR are positioned about 108
counterclockwise from those on the A6 TCR; homolo- (Garcia et al., 1996) than that of MHC-bound A6 TCR
(Garboczi et al., 1996a). (A difference in a Va±Vb inter-gous residues are positioned about 5 AÊ differently (Fig-
ure 1A). At the opposite or MHC-distal ends of the V face similar to that seen in Figure 1D is discussed with
respect to the N15 TCR/Fab complex by Wang et al.domains, the differences in position are larger: homolo-
gous Va residues are rotated about 108, with about 7 AÊ [1998]). The shorter CDR3 loops in B7 also facilitate
closer contact between Vb and the MHC molecule.displacements (Figure 1B), and Vb residues about 208
with nearly 14 AÊ displacements (Figure 1B). As seen in The Ca domain made no crystal lattice contacts in
the crystals of the A6 TCR/HLA-A2/Tax peptide complexFigure 1C, the Vb domain of the B7 TCR (red) is tipped
closer to the MHC molecule (direction of arrow) than is and was disordered, so that no reliable model of it could
be built (Garboczi et al., 1996a). In the B7 TCR/HLA-the Vb domain of the A6 TCR (green). This allows con-
tacts between the B7 Vb CDR2 and MHC that does not A2/Tax peptide crystals studied here, the Ca domain
structure was clear in the electron density maps. Theretake place in the A6 TCR ternary complex.
The small differences in bound TCR orientations result are several crystal lattice contacts to the Ca domain
that apparently stabilized its structure. This now enablesfrom a difference in the relationship of Va to Vb in the
two TCRs (Figure 1D). To appreciate the difference in us to compare the human B7 Ca structure from an MHC/
peptide complex with the murine Ca structure deter-the Va±Vb interface, it is useful first to consider which
interfaces do not differ. The b chains of the two TCRs mined from the uncomplexed 2C TCR (Garcia et al.,
1996). The two structures superimpose very closely (rmssuperimpose nearly perfectly, indicating a very similar
ªelbowº angle in b chains between Cb and Vb, as noted deviation 5 0.86 AÊ ), suggesting that the Ca domain does
not alter its structure upon complexformation. (Fourteenpreviously (Bentley et al., 1995; Garboczi et al., 1996a;
Garcia et al., 1996; Wang et al., 1998). Similarly, the residues of B7 [see Experimental Procedures] are not
defined in the current model.) The mouse 2C TCR con-polar Ca±Cb interfaces superimpose well and are nearly
identical to the Ca±Cb interfaces seen in two uncom- tains both oligosaccharides and the interchain disulfide
bond that were omitted in the B7 construct, but theplexed TCRs, 2C and N15 (Garcia et al., 1996; Wang et
Crystal Structure of B7 TCR/MHC/Peptide Complex
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Figure 1. Comparison of the Diagonal Binding Modes of the Human B7 TCR and A6 TCR Bound to the HLA-A2/HTLV-1 Tax Peptide Complex
(A) Shown are the three variable or CDR loops of B7 TCR Va (red) and Vb (yellow); A6 TCR (blue); HLA (dark blue); and peptide (white). The
variable loop 4 of Va is omitted because it makes no contacts in the B7 TCR complex.
(B) The Va and Vb domains of each TCR bound to HLA-A2 (colors as in [A]). The a1a2 domains of HLA-A2 from each TCR/MHC structure are
superimposed.
(C) TCR/HLA-A2/Tax complexes are compared by superimposing the HLA-A2 (blue) molecule. B7 TCR (red); A6 TCR (green). B7±CDR2b
contacts HLA-A2 (arrow); A6±CDR2b does not.
(D) Va (blue)±Vb (red) interface in B7 and A6 (light colors). b chains of B7 and A6 are superimposed.
Figure drawn with RIBBONS (Carson, 1991).
similarity of the Ca domains indicates that these are not ways. First, the same 13 TCR positions in B7 (13 of 17)
and in A6 (13 of 20) contact the MHC/Tax surface, evencritical for the domain's structure. The average crystallo-
graphic B factor, an indication of the degree of crystal- though they are different amino acids in each receptor
(underline, Figure 2A). Second, the same 18 MHC/Taxline order, for the Ca domain of B7 is larger than for any
other domain in the crystal (Table 1), suggesting that atoms are contacted in the interfaces by both the B7
and the A6 TCRs (red and blue lines, Figure 2B). Seventhe domain may require CD3 components to stabilize it
(see also Garboczi et al., 1996a; Garcia et al., 1996). of these MHC/Tax atoms are contacted by identical
atoms in B7 and A6 (double red lines, Figure 2B and full
underline, Table 2). The other 11 MHC/Tax atoms in bothDifferent TCR Amino Acids Produce
the Same Diagonal Binding interfaces are contacted by homologous TCR positions
(red and blue lines, Figure 2B and short underline, TableWhat causes the same mode of binding of the two differ-
ent TCRs, B7 and A6, to HLA-A2/Tax when only one 2). These atomic contacts include five from main chain
atoms of the TCRs to main chain and one side chainTCR residue (Ser51a) of the 17 TCR residues in the
interface is conserved (arrow, Figure 2B and bold, Table atom of the peptide (Figure 2C). Third, an additional four
atomic contacts are made from both TCRs to the same2)? The TCR/MHC/Tax interface is conserved in three
Immunity
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Figure 2. B7 TCR Interactions with HLA-A2 and Tax Peptide
(A) Partial amino acid sequences of the B7 and A6 TCRs. Residues that contact MHC/peptide are underlined and bold. Dashes signify residues
omitted for brevity. A6 numbering as in Garboczi et al., 1996a. B7a: N region 5 93±96, J region 5 102±116; B7b: N region 5 97±10, J region 5
104±117; A6a: N region 5 92, J region 5 93±116; A6b: N regions 5 95±96 and 102±103, D region 5 97±101, J region 5 105±117.
(B) TCR contacts. B7/A6 conserved contact (arrow and thick blue line); same atoms contacted by B7 and A6 (double red lines); same atoms
on peptide contacted by different TCR atoms in B7 and A6 (single red lines); same atoms on MHC contacted by different TCR atoms in B7
and A6 (blue lines); and novel contacts from B7 TCR to peptide (red dotted lines) and MHC (green dotted lines). Conserved MHC residue
contacts (solid circles); polymorphic MHC residue contacts (open circles); and prominent MHC features shared by many alleles (double circles).
For clarity, the peptide is shown as a straight line, HLA (black), TCR CDRs (red).
(C) B7 contacts to Tax peptide when bound to HLA-A2. The peptide conformation in the B7 TCR complex is essentially identical to that in
the A6 TCR complex (Garboczi et al., 1996a). Residues that are homologous in the B7 and A6 TCR structures and that make some of the
same contacts to Tax are positioned identically in Figures 3C and 3D and are marked with asterisks. Potential hydrogen bonds (red dotted
lines).
(D) A6 contacts to Tax peptide when bound to HLA-A2 (Garboczi et al., 1996a).
(B±D) Figures drawn with MOLSCRIPT (Kraulis, 1991) and RASTER3D (Merritt and Murphy, 1994).
MHC residues (58, 69, 72, and 155), although to different in the two TCRs (labels positioned identically and marked
with asterisks in Figures 2C and 2D), make very similaratoms on those residues (short underline, Table 2).
Among the new contacts (green dashed lines, Figure contacts to the peptide. These contacts include two
hydrogen bonds to the peptide main chain atoms P4-O2B) are two from CDR2b (Y48 and I54) of B7, which is
tilted toward the a1 domain of HLA-A2 (arrow, Figure and P8-N (red dots, Figures 2C and 2D). Surface dia-
grams of the two TCRs shows some similarity in their1C). (No contacts were made by CDR2b of A6 [Garboczi
et al., 1996a]). topological features, such as the deep pocket that binds
the peptide tyrosine side chain at P5 (Figure 3). TheThe conformation of the bound Tax peptide is essen-
tially identical in the B7 and A6 TCR/MHC complexes electrostatic potential (blue is positive and red is nega-
tive, Figure 3), however, illustrates how the two TCRs(Figures 2C and 2D). Recognition of the peptide by the
two TCR is also very similar. Six residues, homologous employ very different chemistries in their interactions
Crystal Structure of B7 TCR/MHC/Peptide Complex
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Table 2. ContinuedTable 2. Contacts between B7 TCR and HLA-A2 / Tax
CDR3 aCDR1 a
a 27 S O HC 167W * NE1 a 95 G CA Tax 4 G O
O HC 167W CZ2 C Tax 4 G O
C HC 167W CZ2 O Tax 5 Y * OH
a 28 M CG Tax 1 L CD1 C Tax 5 Y OH
CE HC 59 Y CA
a 96 A N Tax 4 G * O
CE HC 59 Y CD2
CB Tax 4 G OCE HC 167W CH2
CB Tax 5 Y CD2a 30 D OD2 Tax 4 G CA
CB Tax 5 Y CE2OD1 Tax 5 Y * OH
a 102 Q C HC 65 R NH1OD2 Tax 5 Y CE1
OE1 HC 69 A CBCG Tax 5 Y CE1
a 103 K N HC 65 R NH1a 31 Y CB Tax 5 Y OH
CB HC 65 R NH1
CG Tax 5 Y OH
CB HC 65 R CZ
CD2 Tax 5 Y OH
CDR2 bCG HC 155 Q NE2
b 48 Y OH HC 65 R CDCDR2 a
CZ HC 65 R CDa 50 S OG HC155 Q OE1
b 54 I CD1 HC 72 Q OE1OG HC 158 A CB
CDR3 ba 51 S OG HC 158 A * O
b 98 G CA Tax 6 P OOG HC158 A CB
O Tax 7 V CG1OG HC 158 A C
O Tax 7 V CAOG HC 163 T CG2
O Tax 7 V Ca 52 I CG2 HC 158 A O
O Tax 8 Y * NCG2 HC 158 A CA
CD1 HC 158 A CA O Tax 8 Y CG
CG2 HC 162 G N O Tax 8 Y CD2
CDR3 a C Tax 8 Y CD2
a 93 M CE Tax 5 CE2 b 104 Y CD2 Tax 5 Y CD2
CG Tax 5 Y CD2CE Tax 5 Y OH
OH HC 150 A OCB Tax 5 Y OH
a 94 E OE1 HC 58 E O
Asterisks, hydrogen bonds (2.5±3.4 AÊ ); no asterisks, van der Waals
OE1 HC 62 G CA
contacts (,4.0 AÊ ); full underline, identical atoms in B7 and A6 TCR
OE1 HC 65 R * NH2
contact to identical MHC/peptide atoms; intermediate underline,
O HC 65 R * NH2 MHC/peptide atoms contacted in both B7 and A6 TCR complexes,
O HC 65 R * NH1 but by different TCR atoms; short underline, MHC/peptide residues
O HC 65 R CZ contacted by both TCR, but at different atoms of the residue; bold,
CG HC 65 R NH2 the only B7/A6 conserved contact.
CD HC 65 R NH2
P5, and P8) are also exposed in class II MHC/peptide
complexes (reviewed by Stern and Wiley, 1994). Thewith peptide. For example, the P5 binding pocket is
negatively charged in B7 and positively charged in A6. existence of a general binding mode for TCR/MHC/pep-
tide interactions suggests that the shape of the trimolec-Overall, the common contacts (Figure 2B) that the
two different TCRs make with HLA-A2/Tax gives the ular complex is conserved for some purpose, possibly
to be recognized as the cue to initiate signaling. Sinceimpression that the TCRs land, especially with CDR2a
and CDR3a, on prominent features of MHC molecules this study was submitted for publication two more TCR/
MHC/peptide complexes have been reported with simi-shared by many alleles,such as the freecarbonyl oxygen
at the end of the first helix in the a2 domain (residue lar diagonal binding modes (Garcia et al., 1998; Teng et
al., 1998).150) and the conserved residues at 72, 155, and 158
(double circles, Figure 2B), aligning CDR1a and espe-
cially CDR3a and CDR3b to recognize most of the ex- T Cell Responses to Singly Substituted Peptides
Although the responses of both the B7- and A6-bearingposed section of the peptide (Figures 2C and 2D). Similar
TCR alignments could contact most of the same peptide T cell clones to the Tax peptide are very similar, they
differ in their responses to Tax peptides by single aminoatoms, including the main chain oxygens at P4 and P6
and the nitrogen at P8, on other class I MHC molecules, acid substitutions. The Tax peptide induces a strong
agonist response in both T cell clones, eliciting lysisbecause these peptide atoms are exposed in the nine
known HLA-A2 structures (Madden et al., 1993; Collins and the secretion of interferon-g (IFNg) and macrophage
inflammatory protein 1b (MIP-1b) (Figure 4). Substitutionet al., 1994; Bouvier et al., submitted) and the HLA-
Aw68, -B27, -B35, -B53, and -B8 and H-2Kb structures of a smaller residue, alanine, at P5 (Y5A) results in weak
agonist responses in the A6/2G4 clone (see Experimen-(Madden et al., 1991; Fremont et al., 1992; Guo et al.,
1992; Madden and Wiley, 1992; Madden et al., 1992; tal Procedures) butnull responses in the B7 clone (Figure
4). Substitution of a larger residue, tryptophan, at P5Matsumura et al., 1992a, 1992b;Silver et al., 1992; Zhang
et al., 1992; Reid et al., 1996; Smith et al., 1996a, 1996b). (Y5W) also produces weak responses in 2G4, whereas
clone B7 responds to Y5W with a partial agonist re-Similarly positioned, peptide main chain atoms (P6-O,
P7-Ca, and P8-N) and side chains (including P2, P3, sponse by producing lysis but no responses for IFNg
Immunity
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Figure 3. The Two TCR Surfaces That Contact the Same MHC/Peptide Complex
(A) The molecular surface of the B7 TCR with a ball-and-stick model of the bound Tax peptide superimposed. Surface color: red, negative
electrostatic charge potential; blue, positive.
(B) The molecular surface of the A6 TCR with a ball-and-stick model of the bound Tax peptide superimposed.
Figure drawn with GRASP (Nicholls et al., 1991).
and MIP-1b (Figure 4). The opposite effect, a null ligand Structural Basis for the Differences in B7
and A6 T Cell Responsesfor the A6/2G4 clone but a partial agonist ligand for the
B7 clone, is produced by the substitution of a smaller The B7 and A6 TCR/HLA-A2/Tax structures allow us to
propose the structural basis for the differences in T cellresidue, alanine, at P8 (Y8A) (Figure 4 and Table 3).
Figure 4. T Cell Response Assays
Reactivity of HTLV-1 Tax±specific CTL clones
2G4 and B7 to single±amino acid substituted
Tax peptides. 2G4 and B7 were assayed for
their capacities to lyse or secrete IFNg or
MIP-1b when presented with HLA-A2±trans-
fected Hmy2.C1R cells pulsed with varying
concentrations of Tax 11±19 (squares) or Tax
peptides with the single amino acid substitu-
tions Y5A (upward triangles), Y5W (circles),
or Y8A (downward triangles).
Crystal Structure of B7 TCR/MHC/Peptide Complex
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Table 3. Altered Tax Peptides Have Differential Effects on Functions of A6 and B7 T Cell Clones
A6 B7
Peptide Cytotoxicity IFNg MIP-1b Cytotoxicity IFNg MIP-1b
Tax A A A A A A
Y5A P/ W P /W P /W N N N
Y5W P/ W P /W P /W P/ W N N
Y8A N N N P/ W N N
Cytotoxicity was measured by release of a fluorescence-enhancing ligand (BATD) (Wallac Instruments) as described by Blomberg et al. (1996).
IFNg and MIP-1b secretion by T cell clones was induced as described by Garboczi et al. (1996b) and quantitated by sandwich ELISA assays
as described by the manufacturer (R&D Systems).
A, full agonist activity; P/ W, partial/weak agonist activity (required $10-fold higher concentration of peptide relative to Tax peptide to achieve
same level of effector function); N, null ligand (no measurable activity).
responses that we have measured (Table 3 and Figure are expected to be in contact with the CD3 signaling
subunits. While differences in the position of Va relative4). For example, the peptide with the Y5A substitution
is a null ligand for B7 but a partial agonist for A6/2G4 to the other TCR domains have been observed (Figure
1D), there are differences among both the bound andT cells, probably because the TCR pocket surrounding
Y5 is tighter (smaller) and more specific on B7 than A6/ the unbound TCRs, suggesting the capacity for induced
fit to MHC/peptide complexes tomaximize binding (Gar-2G4, so that loss of those contacts in Y5A would have
a greater effect on B7 T cells. The activity of Y5W, where boczi et al., 1996a; Garcia et al., 1996) rather than spe-
cific conformations for signaling and lack of signaling.the large tryptophan substitution can still fit into the A6
pocket to be a weak agonist but cannot fit into the If TCR signals are initiated by TCR/MHC/peptide com-
plexes with long half-lives, as suggested by current evi-smaller B7 pocket (at least without costly distortions)
so that it is a partial agonist ligand for B7 T cells, is dence (e.g., Lyons et al., 1996), then why is the diagonal
binding mode conserved? Presumably an Fab-like mole-consistent with this proposal. The peptide with the Y8A
substitution is a partial agonist for B7 T cells but a null cule such as the TCR could form long-lived complexes
with other geometries, but apparently those TCRs eitherligand for A6/2G4 T cells, probably because the CDR1b
residue Glu30, common to both TCRs, is positioned are not selected during repertoire maturation or have
not been favored during evolution. Signal initiation as ato make a hydrogen bond only to the peptide tyrosine
hydroxyl group in the A6 complex (compare Figures result of a simple gathering of TCRs in a region of the
T cell membrane (Janeway et al., 1989) would not seem2C and 2D). A6/2G4 T cells are then apparently more
sensitive to the loss of the interactions that tyrosine in to require a general mode (diagonal) of TCR binding.
One explanation for a long±half-life, single binding modeY8A has with this more specific site. The explanations
proposed here do not require conformational changes, is conservation of the geometry of ab TCR/MHC/peptide
complexes so that their formation can be recognizedconsistent with proposals that the activity differences
of the two clones are caused by differences in the life- by another molecule, such as a coreceptor (e.g., Hampl
et al., 1997) or by the TCR/MHC/peptide complex itselftimes of the TCR/MHC complexes, reflected in dissocia-
tion equilibrium or rate constants, rather than allosteric (forming an oligomer) (Brown et al., 1993; Reich et al.,
1997). Signaling then would result from a molecular as-conformational changes (e.g., Lyons et al., 1996).
sembly process, initiated by the formation and persis-
tence of a TCR/MHC/peptide complex. The structuralDiscussion
differences between the B7 and A6/MHC/peptide com-
plexes (Figure 1) suggest that any such assembly mech-The differences observed in the diagonal binding of the
B7 and A6 TCRs to the same MHC/peptide complex anism must have somewhat flexible requirements, so
that the slightly different shapes of the TCR/MHC/pep-limit the possible mechanisms of signal initiation in T
cell activation. Despite the conformational differences tide complexes can all be accommodated.
shown in Figure 1, both TCR/MHC/peptide complexes
initiate the same strong agonist signal. If TCR signals Experimental Procedures
are activated by a TCR conformational change upon
Expression, Refolding, and Assemblybinding MHC/peptide, both the B7 TCR and the A6 TCR
Soluble B7 ab TCR was refolded after expression in bacteria as wasbound conformations must contain this conformational
the A6 TCR (Garboczi et al., 1996b), but from genes (ADV21S1A1N2,alteration. We find no evidence for a conformational
Va17.2-Ja54; BV13S1, Vb12.3-Jb2.7-Cb2) (Arden et al., 1995) iso-
difference in the Cb chain among uncomplexed TCRs lated from a second patient also infected with HTLV-1 virus and
(Garcia et al., 1996; Wang et al., 1998), an isolated Cb having HAM/TSP (Utz et al., 1996). The ectodomains expressed are
residues Gln1 to Ser210 of the a chain and Asn1 to Asp247 of thechain (Bentley et al., 1995), and the B7 and A6 TCRs
b chain. Both chains terminate immediately before the position ofcomplexedwith MHC/peptide. Similarly, the relationship
the interchain disulfide bond, as in the earlier construction of theof the two C domains, Ca and Cb, to each other is the
A6 TCR (Garboczi et al., 1996b). The free cysteine at residue 192same in two uncomplexed TCRs (Garcia et al., 1996;
of the b chain was mutated to a alanine.
Wang et al., 1998) as it is in the B7 TCR complexed with Because dissociation of the a and b chains during purification
HLA-A2/Tax. Thus, there is no evidence for conforma- lowered the yield (,1 mg/liter) of the B7 TCR, it was refolded by
dilution in the presence of excess (20 mg/liter)HLA-A2/Tax complex,tional changes transmitted to the TCR C domains that
Immunity
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itself previously refolded after bacterial expression. The B7 TCR/ by incubation in medium alone. Plates were incubated for 2 hr at
378C. Twenty microliters of supernatant were harvested from eachHLA-A2/Tax peptide complex was purified by gel filtration chroma-
tography (Superdex 200, Pharmacia Biotech). well and added to wells containing 200 ml of 50 mM Europium solu-
tion (Aldrich Chemical, Milwaukee, WI) in 0.3 M acetic acid (pH 4).
Plates were shaken for 5 min at room temperature and the fluores-X-Ray Structure Determination
cence of the Europium-TDA chelates formed was quantitated in aThe B7 TCR/HLA-A2/Tax peptide complex was concentrated to 10
time-resolved fluorometer (DELFIA 1234, Wallac). The mean per-mg/ml and crystallized in 12% PEG 8000, 20 mM MOPS, 100 mM
centage specific lysis was calculated as: (experimental release 2magnesium acetate (pH 7.1). The space group and unit cell con-
spontaneous release)/(Triton X-100 release 2 spontaneous re-stants were determined to be: P212121, a 5 63.8 AÊ , b 5 73.3 AÊ , c 5
lease) 3 100.217.7 AÊ ; one complex per asymmetric unit.
IFNg and MIP-1b secretion was induced in 2G4 and B7 T cells byX-ray data were collected from crystals soaked in 20% glycerol
culturing 96-well round-bottom plates at 5 3 104 cells/well. Antigen-and flash-cooled to 1008K. Low-resolution diffraction data (15.0±3.6
presenting cells were HLA-A2±transfected Hmy2.C1R cells thatAÊ ) were collected with an Elliot GX-13 rotating anode x-ray source
were treated with mitomycin C (200 mg/ml; Sigma) and pulsed withwith the beam collimated by double mirrors and were recorded on
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